These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36536644)

  • 1. Leptin Deficiency May Influence the Divergence of Cell-Mediated Immunity Between Lepromatous and Tuberculoid Leprosy Patients.
    Degechisa ST; Dabi YT
    J Inflamm Res; 2022; 15():6719-6728. PubMed ID: 36536644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocity between Regulatory T Cells and Th17 Cells: Relevance to Polarized Immunity in Leprosy.
    Sadhu S; Khaitan BK; Joshi B; Sengupta U; Nautiyal AK; Mitra DK
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004338. PubMed ID: 26751584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell regulation in lepromatous leprosy.
    Bobosha K; Wilson L; van Meijgaarden KE; Bekele Y; Zewdie M; van der Ploeg-van Schip JJ; Abebe M; Hussein J; Khadge S; Neupane KD; Hagge DA; Jordanova ES; Aseffa A; Ottenhoff TH; Geluk A
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2773. PubMed ID: 24722473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fate of T Cells and their Secretory Proteins During the Progression of Leprosy.
    Tarique M; Saini C; Naz H; Naqvi RA; Khan FI; Sharma A
    Curr Protein Pept Sci; 2018; 19(9):889-899. PubMed ID: 28847289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T helper cells in leprosy: An update.
    Saini C; Tarique M; Rai R; Siddiqui A; Khanna N; Sharma A
    Immunol Lett; 2017 Apr; 184():61-66. PubMed ID: 28235552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
    Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
    Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging Concepts of Adaptive Immunity in Leprosy.
    Sadhu S; Mitra DK
    Front Immunol; 2018; 9():604. PubMed ID: 29686668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Th1/Th2 and macrophage lineage cytokines in leprosy; correlation with circulating CD4(+) CD25(high) FoxP3(+) T-regs cells.
    Abdallah M; Attia EA; Saad AA; El-Khateeb EA; Lotfi RA; Abdallah M; El-Shennawy D
    Exp Dermatol; 2014 Oct; 23(10):742-7. PubMed ID: 25109693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in TGF-β secreting CD4⁺CD25⁺ FOXP3⁺ T regulatory cells in anergic lepromatous leprosy patients.
    Saini C; Ramesh V; Nath I
    PLoS Negl Trop Dis; 2014; 8(1):e2639. PubMed ID: 24454972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudoepitheliomatous hyperplasia and transepidermal elimination in lepromatous leprosy: does T-cell plasticity play a role?
    Fischer MK; Myer KA; Que SK; Harris JA; Martiniuk FT; Meehan SA; Levis WR
    J Drugs Dermatol; 2012 Oct; 11(10):1232-5. PubMed ID: 23134990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factors STAT-4, STAT-6 and CREB regulate Th1/Th2 response in leprosy patients: effect of M. leprae antigens.
    Upadhyay R; Dua B; Sharma B; Natrajan M; Jain AK; Kithiganahalli Narayanaswamy B; Joshi B
    BMC Infect Dis; 2019 Jan; 19(1):52. PubMed ID: 30642265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of transforming growth factor-beta isoforms and their receptors in lepromatous and tuberculoid leprosy.
    Kiszewski CA; Becerril E; Baquera J; Aguilar LD; Hernández-Pando R
    Scand J Immunol; 2003 Mar; 57(3):279-85. PubMed ID: 12641657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines as biomarkers to monitoring the impact of multidrug therapy in immune response of leprosy patients.
    Cassirer-Costa F; Medeiros NI; Chaves AT; Lyon S; Coelho-Dos-Reis JGA; Ribeiro-Junior AF; Correa-Oliveira R; Rocha MOC; Gomes JAS
    Cytokine; 2017 Sep; 97():42-48. PubMed ID: 28570932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling lymphocytic activation molecule expression and regulation in human intracellular infection correlate with Th1 cytokine patterns.
    García VE; Quiroga MF; Ochoa MT; Ochoa L; Pasquinelli V; Fainboim L; Olivares LM; Valdez R; Sordelli DO; Aversa G; Modlin RL; Sieling PA
    J Immunol; 2001 Nov; 167(10):5719-24. PubMed ID: 11698444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of regulatory T cells and down-regulatory molecules in lepromatous leprosy.
    Palermo ML; Pagliari C; Trindade MA; Yamashitafuji TM; Duarte AJ; Cacere CR; Benard G
    Am J Trop Med Hyg; 2012 May; 86(5):878-83. PubMed ID: 22556091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FoxP3 provides competitive fitness to CD4⁺CD25⁺ T cells in leprosy patients via transcriptional regulation.
    Kumar S; Naqvi RA; Ali R; Rani R; Khanna N; Rao DN
    Eur J Immunol; 2014 Feb; 44(2):431-9. PubMed ID: 24214631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.